Lucia Buccarello

Dr. Lucia Buccarello

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KHkambiz Hassanzadeh
kambiz Hassanzadeh
LBLucia Buccarello
Lucia Buccarello
JDJessica Dragotto
Jessica Dragotto
AMAsadollah Mohammadi
Asadollah Mohammadi
MCMassimo Corbo
Massimo Corbo
MFMarco Feligioni
Marco Feligioni
Among the extensive public and scientific interest in the use of phytochemicals to prevent or treat human diseases in recent years, natural compounds have been highly investigated to elucidate their therapeutic effect on chronic human diseases including cancer, cardiovascular disease, and neurodegenerative disease. Curcumin, an active principle of the perennial herb Curcuma longa, has attracted an increasing research interest over the last half-century due to its diversity of molecular targets, including transcription factors, enzymes, protein kinases, growth factors, inflammatory cytokines, receptors, and it’s interesting pharmacological activities. Despite that, the clinical effectiveness of the native curcumin is weak, owing to its low bioavailability and rapid metabolism. Preclinical data obtained from animal models and phase I clinical studies done in human volunteers confirmed a small amount of intestinal absorption, hepatic first pass effect, and some degree of intestinal metabolism, might explain its poor systemic availability when it is given via the oral route. During the last decade, researchers have attempted with new pharmaceutical methods such as nanoparticles, liposomes, micelles, solid dispersions, emulsions, and microspheres to improve the bioavailability of curcumin. As a result, a significant number of bioavailable curcumin-based formulations were introduced with a varying range of enhanced bioavailability. This manuscript critically reviews the available scientific evidence on the basic and clinical effects and molecular targets of curcumin. We also discuss its pharmacokinetic and problems for marketing curcumin as a drug.

6 July 2020 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
KHKambiz Hassanzadeh
Kambiz Hassanzadeh
HPHelena Perez Pena
Helena Perez Pena
JDJessica Dragotto
Jessica Dragotto
LBLucia Buccarello
Lucia Buccarello
FIFederico Iorio
Federico Iorio
MFMarco Feligioni
Marco Feligioni

3 August 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
LBLucia Buccarello
Lucia Buccarello
ASAlessandra Sclip
Alessandra Sclip
MSMatteo Sacchi
Matteo Sacchi
ACAnna Maria Castaldo
Anna Maria Castaldo
IBIlaria Bertani
Ilaria Bertani
TBTiziana Borsello
Tiziana Borsello
The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of alzheimer disease suggesting a correlation between ocular and brain pathologies The c-Jun N-Terminal Kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies

1 January 2017 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
SBSilvia Biggi
Silvia Biggi
LBLucia Buccarello
Lucia Buccarello
ASAlessandra Sclip
Alessandra Sclip
PLPellegrino Lippiello
Pellegrino Lippiello
NTNoemi Tonna
Noemi Tonna
TBTiziana Borsello
Tiziana Borsello
The c-Jun N-terminal kinase (JNK) is part of a stress signalling pathway strongly activated by NMDA-stimulation and involved in synaptic plasticity. Many studies have been focused on the post-synaptic mechanism of JNK action, and less is known about JNK presynaptic localization and its physiological role at this site. Here we examined whether JNK is present at the presynaptic site and its activity after presynaptic NMDA receptors stimulation. By using N-SIM Structured Super Resolution Microscopy as well as biochemical approaches, we demonstrated that presynaptic fractions contained significant amount of JNK protein and its activated form. By means of modelling design, we found that JNK, via the JBD domain, acts as a physiological effector on T-SNARE proteins; then using biochemical approaches we demonstrated the interaction between Syntaxin-1-JNK, Syntaxin-2-JNK, and Snap25-JNK. In addition, taking advance of the specific JNK inhibitor peptide, D-JNKI1, we defined JNK action on the SNARE complex formation. Finally, electrophysiological recordings confirmed the role of JNK in the presynaptic modulation of vesicle release. These data suggest that JNK-dependent phosphorylation of T-SNARE proteins may have an important functional role in synaptic plasticity.

15 December 2021 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
LBLucia Buccarello
Lucia Buccarello
JDJessica Dragotto
Jessica Dragotto
KHKambiz Hassanzadeh
Kambiz Hassanzadeh
RMRita Maccarone
Rita Maccarone
MCMassimo Corbo
Massimo Corbo
MFMarco Feligioni
Marco Feligioni
Retinal ganglion cell (RGC) loss is a pathologic feature common to several retinopathies associated to optic nerve damage, leading to visual loss and blindness. Although several scientific efforts have been spent to understand the molecular and cellular changes occurring in retinal degeneration, an effective therapy to counteract the retinal damage is still not available. Here we show that eyeballs, enucleated with the concomitant optic nerve cut (ONC), when kept in PBS for 24 h showed retinal and optic nerve degeneration. Examining retinas and optic nerves at different time points in a temporal window of 24 h, we found a thinning of some retinal layers especially RGC’s layer, observing a powerful RGC loss after 24 h correlated with an apoptotic, MAPKs and degradative pathways dysfunctions. Specifically, we detected a time-dependent increase of Caspase-3, -9 and pro-apoptotic marker levels, associated with a strong reduction of BRN3A and NeuN levels. Importantly, a powerful activation of JNK, c-Jun, and ERK signaling (MAPKs) were observed, correlated with a significant augmented SUMO-1 and UBC9 protein levels. The degradation signaling pathways was also altered, causing a significant decrease of ubiquitination level and an increased LC3B activation. Notably, it was also detected an augmented Tau protein level. Curcumin, a powerful antioxidant natural compound, prevented the alterations of apoptotic cascade, MAPKs, and SUMO-1 pathways and the degradation system, preserving the RGC survival and the retinal layer thickness. This ex vivo retinal degeneration model could be a useful method to study, in a short time window, the effect of neuroprotective tools like curcumin that could represent a potential treatment to contrast retinal cell death.

20 February 2017 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
LBLucia Buccarello
Lucia Buccarello
GGGiuliano Grignaschi
Giuliano Grignaschi
ACAnna Maria Castaldo
Anna Maria Castaldo
AGALESSIA DI GIANCAMILLO
ALESSIA DI GIANCAMILLO
CDCinzia Domeneghini
Cinzia Domeneghini
TBTiziana Borsello
Tiziana Borsello
P301L transgenic (tg) mice well mimic features of human tauopathies and provide a good model for investigating the role of tau in neurodegenerative events. We here analyzed the possible interactions among phosphorylation of tau (p-tau), spine injury, neuronal death, and sex in the P301L mouse model of tauopathy. When compared to control mice (ctr), P301L transgenic mice (tg) presented a lower body weight, reduced survival rate, hyperphosphorylated tau, spine injury, and neuronal loss in both cerebral cortex and hippocampus at 15 months of age. Importantly, we found that pathological features were more pronounced in female than male tg mice. Recent reports underline that tau may be localized within both pre- and post-synaptic compartments, suggesting that it may possibly induce or contribute to synaptic dysfunction. Therefore, we focused our attention on tau localization at dendritic spines. We detected high levels of both tau and p-tau in dendritic spine of P301L transgenic mice. In addition, p-tau correlated with a significant reduction of post-synaptic markers, such as GluN2A, GluN2B, GluA1, GluA2, Drebrin, and PSD-95, in P301L mice. The p-tau levels are higher in female than in male mice, and the increased p-tau was consistent with a proportional decrease in the post-synaptic marker levels analyzed. The P301L-tg females showed a more severe synaptopathy compared to males. Future investigations on the postsynaptic role of p-tau will be necessary to understand its toxic effects and provide insights into new therapeutic targets for maintaining spine integrity, highlighting the importance of tau toxicity as well as the impact of sex on tau-pathology.